-
1
-
-
0028868527
-
p53: A cell cycle regulator activated by DNA damage
-
Selivanova, G., and Wiman, K. G. p53: a cell cycle regulator activated by DNA damage. Adv. Cancer Res., 66: 143-175, 1995.
-
(1995)
Adv. Cancer Res.
, vol.66
, pp. 143-175
-
-
Selivanova, G.1
Wiman, K.G.2
-
2
-
-
0028171454
-
p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents
-
Fan, S., El-Deiry, W. S., Bae, I., Freeman, J., Jondle, D., Bhatia, K., Fornace, A. J., Jr., Magrath, I., Kohn, K. W., and O'Connor, P. M. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res., 54: 5824-5830, 1994.
-
(1994)
Cancer Res.
, pp. 5824-5830
-
-
Fan, S.1
El-Deiry, W.S.2
Bae, I.3
Freeman, J.4
Jondle, D.5
Bhatia, K.6
Fornace A.J., Jr.7
Magrath, I.8
Kohn, K.W.9
O'Connor, P.M.10
-
3
-
-
0027421045
-
Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines
-
O'Connor,. P. M., Jackman, J., Jondle, D., Bhatia, K., Magrath, I., and Kohn, K. W. Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res., 53: 4776-4780, 1993.
-
(1993)
Cancer Res.
, vol.53
, pp. 4776-4780
-
-
O'Connor P, M.1
Jackman, J.2
Jondle, D.3
Bhatia, K.4
Magrath, I.5
Kohn, K.W.6
-
4
-
-
0027944206
-
p53 status and the efficacy of cancer therapy in vivo
-
Washington DC
-
Lowe, S. W., Bodis, S., McClatchey, A., Reminlon, L., Ruley, H. E., Fisher, D. E., Housman, D. E., and Jacks, T. p53 status and the efficacy of cancer therapy in vivo. Science (Washington DC), 266: 807-810, 1994.
-
(1994)
Science
, vol.266
, pp. 807-810
-
-
Lowe, S.W.1
Bodis, S.2
McClatchey, A.3
Reminlon, L.4
Ruley, H.E.5
Fisher, D.E.6
Housman, D.E.7
Jacks, T.8
-
5
-
-
0028901034
-
Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline
-
Fan, S., Smith, M. L., Rivet, D. J., II, Duha, D., Zhan, Q., Kohn, K. W., Fornace, A. J., Jr., and O'Connor, P. M. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res., 55: 1649-1654, 1995.
-
(1995)
Cancer Res.
, vol.55
, pp. 1649-1654
-
-
Fan, S.1
Smith, M.L.2
Rivet D.J. II3
Duha, D.4
Zhan, Q.5
Kohn, K.W.6
Fornace A.J., Jr.7
O'Connor, P.M.8
-
6
-
-
0030915269
-
Abrogation of p53 function by HPV16 E6 gene delays apoptosis and enhances mutagenesis but does not alter radiosensitivity in TK6 human lymphoblast cells
-
Yu, Y., Li, C-Y., and Little, J. B. Abrogation of p53 function by HPV16 E6 gene delays apoptosis and enhances mutagenesis but does not alter radiosensitivity in TK6 human lymphoblast cells. Oncogene. 14: 1661-1667, 1997.
-
(1997)
Oncogene
, vol.14
, pp. 1661-1667
-
-
Yu, Y.1
Li, C.-Y.2
Little, J.B.3
-
7
-
-
0029054581
-
Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation
-
Tsang, N-M., Nagasawa, H., Li, C., and Little, J. B. Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation. Oncogene, 10: 2403-2408, 1995.
-
(1995)
Oncogene
, pp. 2403-2408
-
-
Tsang, N.-M.1
Nagasawa, H.2
Li, C.3
Little, J.B.4
-
8
-
-
0028788952
-
Tumor suppressor p53 mutations and breast cancer: A critical analysis
-
Ozbun, M. A., and Butel, J. S. Tumor suppressor p53 mutations and breast cancer: a critical analysis. Adv. Cancer Res., 66, 71-128, 1993.
-
(1993)
Adv. Cancer Res.
, vol.66
, pp. 71-128
-
-
Ozbun, M.A.1
Butel, J.S.2
-
9
-
-
0028879677
-
p53 point mutation and survival in colorectal cancer patients
-
Goh, H-S., Yao, J., and Smith, D. R. p53 point mutation and survival in colorectal cancer patients. Cancer Res., 55: 5217-5221, 1995.
-
(1995)
Cancer Res.
, vol.55
, pp. 5217-5221
-
-
Goh, H.-S.1
Yao, J.2
Smith, D.R.3
-
10
-
-
0029080737
-
Clinical and preclinical photodynamic therapy
-
Fisher, A. M. R., Murphree, A. L., and Gomer, C. J. Clinical and preclinical photodynamic therapy. Lasers Surg. Med., 17: 2-31, 1995.
-
(1995)
Lasers Surg. Med.
, vol.17
, pp. 2-31
-
-
Fisher, A.M.R.1
Murphree, A.L.2
Gomer, C.J.3
-
11
-
-
0032540701
-
Photodynamic therapy
-
Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., and Peng, Q. Photodynamic therapy. J. Natl. Cancer Inst., 90: 889-905, 1998.
-
(1998)
J. Natl. Cancer Inst.
, vol.90
, pp. 889-905
-
-
Dougherty, T.J.1
Gomer, C.J.2
Henderson, B.W.3
Jori, G.4
Kessel, D.5
Korbelik, M.6
Moan, J.7
Peng, Q.8
-
12
-
-
0027489384
-
Clinical implications of the p53 tumor suppressor gene
-
Harris, C. C., and Hollstein, M. Clinical implications of the p53 tumor suppressor gene. N. Engl. J. Med., 329: 1318-1327, 1993.
-
(1993)
N. Engl. J. Med.
, vol.329
, pp. 1318-1327
-
-
Harris, C.C.1
Hollstein, M.2
-
13
-
-
0031196011
-
Increased photosensitivity in HL60 cells expressing wild-type p53
-
Fisher, A. M. R., Danenberg, K., Banerjee, D., Bertino, J. R., Danenberg, P., and Gomer, C. J. Increased photosensitivity in HL60 cells expressing wild-type p53. Photochem. Photobiol., 66: 265-270, 1997.
-
(1997)
Photochem. Photobiol.
, vol.66
, pp. 265-270
-
-
Fisher, A.M.R.1
Danenberg, K.2
Banerjee, D.3
Bertino, J.R.4
Danenberg, P.5
Gomer, C.J.6
-
14
-
-
0030294833
-
The induction of partial resistance to photodynamic therapy by the protooncogene BCL-2
-
He, J., Agarwal, M. L., Larkin, H. E., Friedman, L. R., Xue, L-Y., and Oleinick, N. L. The induction of partial resistance to photodynamic therapy by the protooncogene BCL-2. Phatochem. Photobiol., 64: 845-852, 1996.
-
(1996)
Phatochem. Photobiol.
, vol.64
, pp. 845-852
-
-
He, J.1
Agarwal, M.L.2
Larkin, H.E.3
Friedman, L.R.4
Xue, L.-Y.5
Oleinick, N.L.6
-
15
-
-
0032007321
-
Differential photosensitivity in wild-type and mutant p53 human colon carcinoma cell lines
-
Fisher, A. M. R., Rucker, N., Wong, S., and Gomer, C. J. Differential photosensitivity in wild-type and mutant p53 human colon carcinoma cell lines J. Photochem. Photobiol., 42: 104-107, 1998.
-
(1998)
J. Photochem. Photobiol.
, vol.42
, pp. 104-107
-
-
Fisher, A.M.R.1
Rucker, N.2
Wong, S.3
Gomer, C.J.4
-
16
-
-
0027079358
-
The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein
-
Mietz, J. A., Unger, T., Huibregtse, J. M., and Howley, P. M. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J., 11: 5013-5020, 1992.
-
(1992)
EMBO J.
, vol.11
, pp. 5013-5020
-
-
Mietz, J.A.1
Unger, T.2
Huibregtse, J.M.3
Howley, P.M.4
-
17
-
-
0024428508
-
The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes
-
Munger, K., Phelps, W. C., Bubb, V., Howley, P. M., and Schlegel, R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol., 63: 4417-4421, 1989.
-
(1989)
J. Virol.
, vol.63
, pp. 4417-4421
-
-
Munger, K.1
Phelps, W.C.2
Bubb, V.3
Howley, P.M.4
Schlegel, R.5
-
18
-
-
0020530724
-
A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis
-
Vindelov, L. L., Christensen, I. J., and Nissen, N. I. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry, 3: 323-327, 1983.
-
(1983)
Cytometry
, vol.3
, pp. 323-327
-
-
Vindelov, L.L.1
Christensen, I.J.2
Nissen, N.I.3
-
19
-
-
0028898203
-
Potential role of WAF1/Cip1/p21 as a mediator of TGf-β cytoinhibitory effect
-
Li, C. Y., Suardet, L., and Little, J. B. Potential role of WAF1/Cip1/p21 as a mediator of TGF-β cytoinhibitory effect. J. Biol. Chem., 270: 4971-4974, 1995.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 4971-4974
-
-
Li, C.Y.1
Suardet, L.2
Little, J.B.3
-
20
-
-
0027458089
-
Analysis of p53 transactivation through high-affinity binding sites
-
Chumakov, A. M., Miller, C. W., Chen, D. L., and Koeffler, H. P., Analysis of p53 transactivation through high-affinity binding sites. Oncogene, 8: 3005-3011, 1993.
-
(1993)
Oncogene
, vol.8
, pp. 3005-3011
-
-
Chumakov, A.M.1
Miller, C.W.2
Chen, D.L.3
Koeffler, H.P.4
-
21
-
-
0032499679
-
Photodynamic therapy results in p53-independent induction of WAF1/CIP1/P21, leading to cell cycle arrest and apoplosis
-
Ahmad, N., Feyes, D. K., Agarwal, R., and Mukhtar, H. Photodynamic therapy results in p53-independent induction of WAF1/CIP1/P21, leading to cell cycle arrest and apoplosis. Proc. Natl. Acad. Sci. USA, 95: 6977-6982, 1998.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 6977-6982
-
-
Ahmad, N.1
Feyes, D.K.2
Agarwal, R.3
Mukhtar, H.4
-
22
-
-
0028820298
-
A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress
-
Russo, T., Zambrano, N., Esposito, F., Ammendola, R., Cimino, F., Fiscella, M., Jackman, J., O'Connor, P. M., Anderson, C. W., and Appella, E. A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress. J. Biol. Chem., 270: 29386-29391, 1995.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 29386-29391
-
-
Russo, T.1
Zambrano, N.2
Esposito, F.3
Ammendola, R.4
Cimino, F.5
Fiscella, M.6
Jackman, J.7
O'Connor, P.M.8
Anderson, C.W.9
Appella, E.10
-
23
-
-
0029979302
-
The phosphatase inhibitor calyculin antagonizes the rapid initiation of apoptosis by photodynamic therapy
-
Luo, Y., and Kessel, D. The phosphatase inhibitor calyculin antagonizes the rapid initiation of apoptosis by photodynamic therapy. Biochem. Biophys Res. Commun., 221: 72-76, 1996.
-
(1996)
Biochem. Biophys Res. Commun.
, vol.221
, pp. 72-76
-
-
Luo, Y.1
Kessel, D.2
-
24
-
-
0028294605
-
1 arrest and apoptosis
-
1 arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994.
-
(1994)
Cancer Res.
, vol.54
, pp. 1169-1174
-
-
El-Diery, W.S.1
Harper, W.2
O'Cannor, P.M.3
Velculescu, V.E.4
Canman, C.E.5
Jackman, J.6
Pietenpol, J.A.7
Burrell, M.8
Hill, D.E.9
Wang, Y.10
Wiman, K.G.11
Mercer, W.E.12
Kaslan, M.B.13
Kohn, K.W.14
Ellege, S.J.15
Kinzler, K.W.16
Vogelstein, B.17
-
25
-
-
0028177401
-
1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein
-
1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA, 91: 5320-5324, 1994.
-
(1994)
Proc. Natl. Acad. Sci. USA
, pp. 5320-5324
-
-
Slebos, R.J.1
Lee, M.H.2
Plunkett, B.S.3
Klessis, T.D.4
Williams, B.O.5
Jacks, T.6
Hedrick, L.7
Kastan, M.B.8
Cho, K.R.9
-
26
-
-
0026338824
-
Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells
-
Agarwal, M. L., Clay, M. E., Harvey, E. J., Evans, H. H., Antunez, A. R., and Oleinick, N. L. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res., 51: 5993-5996, 1991.
-
(1991)
Cancer Res.
, vol.51
, pp. 5993-5996
-
-
Agarwal, M.L.1
Clay, M.E.2
Harvey, E.J.3
Evans, H.H.4
Antunez, A.R.5
Oleinick, N.L.6
-
27
-
-
0040298568
-
Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis
-
Janicke, R. U., Sprengart, M. L., Wati, M. R., and Porter, A. G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem., 273: 9357-9360, 1998.
-
(1998)
J. Biol. Chem.
, vol.273
, pp. 9357-9360
-
-
Janicke, R.U.1
Sprengart, M.L.2
Wati, M.R.3
Porter, A.G.4
|